Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01MYN
|
||||
Former ID |
DIB011357
|
||||
Drug Name |
LY-2523199
|
||||
Synonyms |
11-beta hydroxysteroid dehydrogenase type 1 inhibitor (diabetes), Eli Lilly; 11-beta-HSD-1 inhibitor (type 2 diabetes), Eli Lilly
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Discontinued in Phase 2 | [549275] | ||
Company |
Eli Lilly & Co
|
||||
Target and Pathway | |||||
Target(s) | Corticosteroid 11-beta-dehydrogenase, isozyme 1 | Target Info | Inhibitor | [549810] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
FSH Signaling Pathway | |||||
PathWhiz Pathway | Steroidogenesis | ||||
Reactome | Glucocorticoid biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.